-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Objective: The ability to regulate the development of B cells has long been thought to have therapeutic potential
Methods: ANTI-BAFF and ANTI-CD20 monoclonal antibodies
Results: The data showed that B cell depletion levels with drug combinations increased compared to the use of drugs alone, leading to significantly more effective clinical and serological responses
In summary, the data show that dual B-cell targeted therapy against BAFF and anti-CD20 not only leads to efficient depletion of B cells in peripheral blood and tissues, but also leads to significant clinical improvement
Source: Zhang W, Shao T, Leung PSC, Tsuneyama K, Heuer L, Young HA, Ridgway WM, Gershwin ME.